BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Combined General Meeting of May 22, 2025 - Availability of the preparatory documents

  May 1, 2025

   · 

  9 min read
• Press Releases

  OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

  May 1, 2025

   · 

  11 min read
• Press Releases

  MIMEDX Announces First Quarter 2025 Operating and Financial Results

  May 1, 2025

   · 

  16 min read
• Press Releases

  Mdxhealth to Release First Quarter 2025 Financial Results on May 14

  May 1, 2025

   · 

  1 min read
• Press Releases

  Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 30, 2025

  May 1, 2025

   · 

  1 min read
• Press Releases

  BIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the company

  May 1, 2025

   · 

  2 min read
• Press Releases

  New Study Shows Castle Biosciences’ DecisionDx®-Melanoma Test Outperforms Staging and CP-GEP in Identifying Patients at Low Risk of Sentinel Lymph Node Positivity

  May 1, 2025

   · 

  8 min read
• Press Releases

  Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations

  May 1, 2025

   · 

  3 min read
• Press Releases

  Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine

  May 1, 2025

   · 

  9 min read
• Press Releases

  OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-902, a Trop-2 Targeting ADC

  May 1, 2025

   · 

  4 min read